Susmed (TSE:4263) Common Stock: 円117.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4263 Susmed Inc TSE:4263
73 GF Score
Price 円690.00
GF Value 円846.73
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Susmed Common Stock?

Susmed TSE:4263 -4.30% 73 Common Stock is 円117.1 Mil as of Dec. 2025. GuruFocus rates TSE:4263 with a GF Score™ of 73/100 and a GF Value™ of 円846.73 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Susmed's quarterly common stock stayed the same from Jun. 2025 (円99.2 Mil) to Sep. 2025 (円99.2 Mil) but then increased from Sep. 2025 (円99.2 Mil) to Dec. 2025 (円117.1 Mil).

Susmed's annual common stock increased from Jun. 2023 (円41.0 Mil) to Jun. 2024 (円81.0 Mil) and increased from Jun. 2024 (円81.0 Mil) to Jun. 2025 (円99.2 Mil).

Susmed Common Stock Historical Data

* Premium members only.

The historical data trend for Susmed's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Susmed Common Stock Chart

Susmed Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial 100.00 1,853.11 40.95 80.96 99.23

Susmed Quarterly Data
Jun20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.20 99.23 99.23 117.10 117.10
TSE:4263
73GF Score
Susmed Inc TSE:4263
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Susmed Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of 円117.1 Mil mean?
Susmed (TSE:4263) has a Common Stock of 円117.1 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Susmed and its competitors.
Is Susmed's Common Stock too high?
Susmed's current Common Stock is 円117.1 Mil. Overall, Susmed has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Susmed's Common Stock compare to VEEV and BTSG?
Susmed's Common Stock of 円117.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Healthcare Providers & Services company?
A good Common Stock depends on the Healthcare Providers & Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Susmed and its competitors. Susmed's current Common Stock is 円117.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Susmed stock overvalued right now?
Based on GuruFocus' analysis, Susmed (TSE:4263) is currently considered Modestly Undervalued. The stock's GF Value™ is 円846.73, compared to a current price of 円690.00 — trading 18.5% below its estimated fair value. The current Common Stock is 円117.1 Mil. Susmed's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Susmed (TSE:4263), the current Common Stock is 円117.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Susmed (TSE:4263) Overvalued in 2026?

Based on GuruFocus' analysis, Susmed stock appears to be undervalued. The current stock price of 円690.00 is trading 18.5% below its estimated GF Value™ of 円846.73. GuruFocus considers Susmed to be Modestly Undervalued.

Key valuation signals for TSE:4263:

  • Common Stock: 円117.1 Mil
  • GF Value™: 円846.73 vs. price of 円690.00 (18.5% below fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the TSE:4263 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Susmed Business Description

Address 3-7-2 Nihonbashi Honcho, 10th Floor, MFPR Nihonbashi Honcho Building, Chuo-ku, Tokyo, JPN, 103-0023
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
73GF Score

Get the complete analysis for TSE:4263

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円690.00
Price
円846.73
GF Value